BCM Oncology Scholars Training Program

描述（由申请人提供）：肿瘤学的转化研究培训需要一个包含多个学科组成部分的指导计划。近年来，缺乏具有临床和实验室研究专业知识的年轻研究人员。为了增加在转化性癌症研究中有才华的内科科学家和博士科学家的数量，我们需要改善培训机会。BCM肿瘤学者培训计划旨在满足医学博士（或医学博士/博士）和博士学员的需求。该计划由五个科研主题组成，包括：(1)“组学”科学（基因组学、蛋白质组学和代谢组学）；(2)肿瘤信号通路；(3)干细胞与发育；(4)治疗和诊断；(5)癌症流行病学与预防。我们将从每个班的贝勒血液学/肿瘤学研究员中选出一名学者，并提供三年的研究支持和指导，从奖学金的下半年开始，一直延伸到初级教师职位的前18个月。为培养肿瘤学转化研究方面的博士，我们还将每年从BCM博士后池中公开选拔1名博士后学者，支持其3年的癌症转化研究。每位学者实习生将接受肿瘤研究方面的培训计划，包括教学课程、职业发展技能和实验室研究指导。每个受训者将接受针对其具体兴趣的指导。通过研究导师和临床教师对医学博士和博士学者的共同指导，以及针对特定项目的研究研讨会系列，拟议的T32将为我们的学员提供一个发展转化性癌症合作研究的平台，并培养他们的职业发展。

DESCRIPTION (provided by applicant): Translational research training in oncology requires a mentoring program with components from multiple disciplines. In recent years, there has been a shortage of young investigators with both clinical and laboratory research expertise. In order to increase the pool of talented physician-scientists and Ph.D. scientists in translational cancer research we need to improve training opportunities. The BCM Oncology Scholars Training Program aims to address the needs of both M.D. (or M.D./Ph.D.) and Ph.D. trainees. The program is composed of five scientific research themes including: (1) "Omics" sciences (genomics, proteomics and metabolomics); (2) Cancer signaling pathways; (3) Stem cells and development; (4) Therapeutics and diagnostics; (5) Cancer epidemiology and prevention. From each class of Baylor hematology/oncology fellows, we will select a scholar and provide three years of research support and mentoring, starting in the second half of the fellowship and extending into the first eighteen months of a junior faculty position. To train Ph.D. the translational research in oncology, we will also select a Ph.D. postdoctoral scholar each year from the BCM postdoctoral pool via open competition and support her/his translational cancer research for three years. Each scholar trainee will receive a training program in oncological research including didactic courses, career development skills and mentored laboratory research. Each trainee will receive mentorship tailored to the specific interests of the trainees. Through co-mentorship for the M.D. and Ph.D. scholars between research mentors and clinical faculty, and a program-specific research seminar series, the proposed T32 will serve as a platform to develop translational cancer collaborative research for our trainees and to nurture their career development.